Announcements Trials
Browse Landscape

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 75Observational 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Prostatic Neoplasms 6Neoplasm Metastasis 2Metastatic Hormone-Sensitive Prostate Cance 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Advanced Prostate Carcinoma 1

Interventions

Surveys and Questionnaires 34Blood Specimen Collection 24enzalutamide 18Radiotherapy 15Docetaxel 15Biopsy 14Abiraterone Acetate 14apalutamide 13Leuprolide 13Interviews as Topic 13Observation 12Magnetic Resonance Spectroscopy 12Watchful Waiting 10radium Ra 223 dichloride 9darolutamide 9Androgen Antagonists 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Radiosurgery 7Magnetic Resonance Imaging 7Brachytherapy 7abiraterone 6Specimen Handling 6Amplified Fragment Length Polymorphism Analysis 6Triptorelin Pamoate 5Standard of Care 5Positron Emission Tomography Computed Tomography 5Gonadotropin-Releasing Hormone 5Focus Groups 5Registries 4Radiotherapy, Intensity-Modulated 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Observational × Prostatic Neoplasms × abiraterone × Clear all
NCT05701007 2026-01-29

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Pfizer

Completed
1,083 enrolled 29 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02125617 2026-01-14

uPARCRPC

Rigshospitalet, Denmark

Terminated
3 enrolled
Genitourinary

Prostatic Neoplasms

NCT06072196 2025-12-31

A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Pfizer

Completed
3,017 enrolled 5 charts
Genitourinary

Prostatic Neoplasms

NCT04034095 2025-12-15

A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

Janssen Pharmaceutical K.K.

Completed
979 enrolled
Genitourinary

Prostatic Neoplasms

NCT02366494 2024-11-25

Micro RNAs to Predict Response to Androgen Deprivation Therapy

Medical College of Wisconsin

Completed
42 enrolled
Genitourinary

Prostatic Neoplasms

NCT05188911 2022-01-12

Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial

Fudan University

Unknown
30 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡